ALACHUA, Fla.--(BUSINESS WIRE)--AGTC (Applied Genetic Technologies Corporation), a privately held clinical stage gene therapy company, is pleased to announce that Dr. Jeffrey Chulay has joined the company as Chief Medical Officer and Vice President of Regulatory Affairs.